Efficacy and Safety of Bosentan in Sickle Cell Disease (SCD) Patients With Pulmonary Arterial Hypertension (PAH)

Clinical trial NCT00310830 · TERMINATED

Trial details

NCT number: NCT00310830
Sponsor: Actelion
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Pulmonary Hypertension

Start date: 2006-03-01
Primary completion: 2007-08-01
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.